Literature DB >> 24328938

The correlation between the comprehensive nutrition index and quality of life of patients with nasopharyngeal carcinoma treated by intensity-modulated radiotherapy.

Liqin Ma1, Tingting Wu, Jianji Pan, Xiangquan Kong, Qiaojuan Guo, Ling Yang, Yu Zhang, Shaojun Lin, Chuanben Chen, Chaobin Huang.   

Abstract

The purpose of this study was to compare the changing tendency of nutrition with 54 nasopharyngeal carcinoma patients during intensity-modulated radiation therapy (IMRT), and to investigate the correlation between comprehensive nutritional status and quality of life (QoL), which was assessed by the European Organization for Research and Treatment of Cancer Core Quality-of-Life Questionnaire. The nutritional index, including body mass index, ideal body weight percentage, usual body weight percentage, albumin, hemoglobin, and total lymphocyte count (TLC), was evaluated at 2 time points: within 48 h after admission (T1) and at the end of treatment with IMRT (T2). A statistically significant downgrade of every index was observed during IMRT. A comprehensive nutritional model was established by principal components analysis at T2. QoL scores of functional (P = 0.002) and the global QoL scales (P = 0.001) existed a positive correlation with comprehensive nutritional status. QoL scores of symptom scales (P = 0.002) and 6 single items (P = 0.005) had a negative correlation with it. The scores of global QoL scales in comprehensive nutrition of normal (20.4%), moderate (55.6%), and severe malnutrition (24.1%) were 69.70 ± 17.98, 48.33 ± 19.25, and 37.18 ± 24.67, respectively. Patients with different nutritional status had different QoL (B = 10.405, SE = 2.828, t = 3.680, P = 0.001). Multiaspect nutritional supports should be enhanced to improve patients' comprehensive nutritional status during treatment.

Entities:  

Mesh:

Year:  2013        PMID: 24328938     DOI: 10.1080/01635581.2014.853815

Source DB:  PubMed          Journal:  Nutr Cancer        ISSN: 0163-5581            Impact factor:   2.900


  6 in total

1.  Prevalence of hospital malnutrition in cancer patients: a sub-analysis of the PREDyCES® study.

Authors:  Mercè Planas; Julia Álvarez-Hernández; Miguel León-Sanz; Sebastián Celaya-Pérez; Krysmarú Araujo; Abelardo García de Lorenzo
Journal:  Support Care Cancer       Date:  2015-06-23       Impact factor: 3.603

2.  Construction of a comprehensive nutritional index and comparison of its prognostic performance with the PNI and NRI for survival in older patients with nasopharyngeal carcinoma: a retrospective study.

Authors:  Yu-Yu Duan; Jun Deng; Dong-Fang Su; Wen-Qiong Li; Yuan Han; Zhen-Xiu Li; Xue-Zhen Huan; Shi-Heng Zhu; Qiu-Lan Yang; Wen Hu; Ming-Zhu Xin; Lin-Quan Tang; Hai-Qiang Mai; Yu-Ying Fan; Yan He
Journal:  Support Care Cancer       Date:  2021-03-08       Impact factor: 3.603

3.  The end-of-treatment telephone response and prognosis of post-radiotherapy nasopharyngeal carcinoma patients in southern China.

Authors:  Mu-Yao Chen; Yu-Shan Chen; Li-Jing Hu; Xue-Ping Lun; Dan-Dan He; Pei-Fen Chen; Lian-Ying Hu
Journal:  Int J Clin Exp Med       Date:  2015-09-15

4.  Skeletal Muscle Mass Measurement Using Cone-Beam Computed Tomography in Patients With Head and Neck Cancer.

Authors:  Wei Huang; Peixin Tan; Hongdan Zhang; Zhen Li; Hui Lin; Youxing Wu; Qinwen Du; Qidi Wu; Jun Cheng; Yu Liang; Yi Pan
Journal:  Front Oncol       Date:  2022-06-28       Impact factor: 5.738

5.  Evaluation of effect of body mass index and weight loss on survival of patients with nasopharyngeal carcinoma treated with intensity-modulated radiation therapy.

Authors:  Yu-Hsuan Lin; Kuo-Ping Chang; Yaoh-Shiang Lin; Ting-Shou Chang
Journal:  Radiat Oncol       Date:  2015-06-30       Impact factor: 3.481

6.  A Bioadhesive Barrier-Forming Oral Liquid Gel Improved Oral Mucositis and Nutritional Status in Patients With Head and Neck Cancers Undergoing Radiotherapy: A Retrospective Single Center Study.

Authors:  Jinlong Wei; Jie Wu; Huanhuan Wang; Bin Wang; Tingting Zhao; Lingbin Meng; Lihua Dong; Xin Jiang
Journal:  Front Oncol       Date:  2021-02-22       Impact factor: 6.244

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.